Panntherapi Advances Epilepsy Treatment with PTI5803 Clinical Trial
Panntherapi prepares for Phase IIa clinical trial of PTI5803 in patients with resistant epilepsy, accelerating…
Panntherapi prepares for Phase IIa clinical trial of PTI5803 in patients with resistant epilepsy, accelerating…
PannTheraPi prepares to conduct its first Phase IIa clinical trial with PTI5803 in patients with…
The Omaha Tribe in Nebraska is making great progress in the rollout of medical marijuana,…
A Wisconsin doctor's groundbreaking research brings new promise to epilepsy patients seeking a seizure-free life
The El Dorado Foundation is providing scholarships to students with epilepsy to support their educational…
Recent studies have shed light on the safety and efficacy of spinal cord stimulation, a…